Latest Market Expectations News

Telix Pharmaceuticals has secured FDA agreement on a resubmission plan for its glioma imaging agent TLX101-CDx, aiming for a Q4 2025 filing that includes additional efficacy data. The FDA signals likely expedited review, underscoring the unmet medical need.

Livium Ltd has inked a term sheet with the University of Melbourne to exclusively commercialise innovative microwave technology for rare earth elements extraction, promising high recovery rates and major energy savings.

Latitude 66 Limited has responded to an ASX price query concerning unusual trading activity, confirming no undisclosed material information exists and referencing prior announcements about a joint venture sale and recent assay results.

Harvey Norman Holdings Limited has responded to ASX inquiries confirming its FY25 earnings aligned with market expectations, despite the absence of formal guidance and complexities in analyst forecasting.

Domino’s Pizza Enterprises faces ASX scrutiny following a steep share price fall after its FY25 results, with regulators seeking clarity on earnings disclosures and market expectations.

SiteMinder Limited has confirmed its FY25 financial results aligned closely with market expectations and analyst forecasts, explaining the recent share price surge following its earnings release.

Australian Gold and Copper Ltd reports standout near-surface gold and silver assay results from its Achilles discovery in NSW, highlighting significant potential for resource expansion amid robust metal prices.

oOh!media has confirmed its half-year earnings for 2025 met market expectations, despite a significant non-cash impairment linked to the loss of a key Auckland Transport contract. The company maintains steady operational performance and updated guidance amid evolving market conditions.

IPH Limited has clarified that its FY25 underlying earnings aligned closely with market consensus, addressing ASX concerns amid a notable share price drop post-results. The company attributes the share price movement to external operational challenges rather than earnings surprises.

Brambles Limited has clarified that its full-year 2025 earnings aligned closely with prior guidance and market expectations, with no material surprises. The company’s robust FY26 outlook, including increased dividends and a significant share buy-back, underpinned positive investor sentiment.

EVT Limited has responded to ASX inquiries confirming its FY25 earnings were broadly in line with market forecasts, despite a notable post-results share price decline.

Codan Limited has clarified that its FY25 financial results aligned closely with market forecasts despite a notable share price jump following its earnings release. The company detailed its compliance with ASX disclosure rules and attributed the price movement to broader macroeconomic factors.